← All trials
NCT05338502
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 8, 2019
- Primary completion
- Sep 3, 2019
- Completion date
- Sep 3, 2019
- First posted
- Apr 21, 2022
- Last posted
- Apr 21, 2022
- Enrollment
- 20
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Eli LillyLead sponsor
- Eli LillyStudy director
- Loxo OncologyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.